Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report
- PMID: 22883745
- PMCID: PMC3469403
- DOI: 10.1186/1752-1947-6-239
Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report
Abstract
Introduction: Valproic acid is a commonly used anti-epileptic drug. Hematological toxicities are among the occasionally observed adverse effects of this medication.
Case presentation: We present the case of a 13-year-old Caucasian boy who demonstrated mild anemia 12 months after the introduction of valproic acid therapy. A bone marrow biopsy revealed maturation arrest of proerythroblasts.
Conclusion: Prompt diagnosis and valproic acid discontinuation resulted in the patient's recovery.
Figures
References
-
- Kanada J, Chonabayashi K, Watanabe M, Arima N, Tsudo M. Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia] [in Japanese. Rinsho Ketsueki. 2005;46:1114–1117. - PubMed
LinkOut - more resources
Full Text Sources